84 related articles for article (PubMed ID: 6157614)
1. Disturbances of desmofibrinogenesis in pateints suffering from acute myeloblastic leukemia.
Kłoczko J; Zuch A; Bielawiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):125-30. PubMed ID: 6157614
[TBL] [Abstract][Full Text] [Related]
2. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
Anders O; Görss EW; Ernst B; Konrad H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen survival with 75-seleniomethionine in acute myeloblastic leukemia during polychemotherapy.
Barbui T; Battista R; Dini E
Haematologica; 1976 Mar; 61(1):73-80. PubMed ID: 820599
[No Abstract] [Full Text] [Related]
4. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
5. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute myeloblastic leukemia in patients over 60. Apropos of 22 cases].
Bernard JF; Garbaz M; Kahn A; Hakim J; Amar M; Boivin P
Nouv Presse Med; 1974 Jun; 3(26):1653-6. PubMed ID: 4526607
[No Abstract] [Full Text] [Related]
7. [Clinical usefulness of determination of the sensitivity of myeloblastic leukemia cells to antiproliferative drugs in cell culture in vivo].
Hansz J; Pytlak B; Drozdowska D
Acta Haematol Pol; 1981; 12(1):1-6. PubMed ID: 6947679
[TBL] [Abstract][Full Text] [Related]
8. [Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia].
Tura S; Ricci P; Baccarani M; Lauria F; Santucci MA
Haematologica; 1972; 57(7):359-70. PubMed ID: 4628583
[No Abstract] [Full Text] [Related]
9. [Experiences in the induction of remission and in maintenance therapy in acute myeloblastic leukemia in adults with the RAMPO scheme].
Höche D; Herold M; Fink R; Anger G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):237-43. PubMed ID: 6168533
[No Abstract] [Full Text] [Related]
10. [Activity of the fibrin-stabilizing factor in acute leukemia].
Tentsova IA
Probl Gematol Pereliv Krovi; 1974; 19(5):33-6. PubMed ID: 4524610
[No Abstract] [Full Text] [Related]
11. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute leukemias].
Gross R; Gerecke D
Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
[TBL] [Abstract][Full Text] [Related]
13. Androgen therapy during myeloblastic leukemia remission induced by two drug combinations.
Pavlovsky S; Scaglione C; Eppinger-Helft M; Muriel FS; Macchi A; Garay G; Cavagnaro F; Birman V; Dupont J; Suarez A; Dragosky MO; Barros CA
Medicina (B Aires); 1981; 41(1):11-8. PubMed ID: 7022104
[No Abstract] [Full Text] [Related]
14. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
Siebenlist KR; Meh DA; Mosesson MW
Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
[TBL] [Abstract][Full Text] [Related]
15. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
Masaoka T; Ogawa M; Yamada K; Kimura K; Ohashi Y
Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of acute myeloblastic leukemia by rubidomycin. Statistics on 35 cases].
Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
Lille Med; 1969 Mar; 14(3):257-63. PubMed ID: 5261958
[No Abstract] [Full Text] [Related]
17. Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.
Löfgren C; Lehmann S; Jönsson-Videsäter K; Möllgård L; Linder O; Tidefelt U; Hassan M; Paul C
Ther Drug Monit; 2007 Oct; 29(5):626-31. PubMed ID: 17898654
[TBL] [Abstract][Full Text] [Related]
18. [Effect of hormonal contraception on the fibrin-stabilizing factor (factor XIII)].
Brandt M; Hofmann KD; Wagner F; Koob P
Zentralbl Gynakol; 1978; 100(17):1089-92. PubMed ID: 716679
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloblastic leukemia in adults.
Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
